Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Hasselt – page 57

1 808 clinical trials in Hasselt, Belgium across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Hasselt at a glance
1 808
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

1 808 trials in Hasselt

Open in trial search

Breast cancer

Recruiting

Study on the Effectiveness of Inavolisib with Trastuzumab and Pertuzumab for Patients with HER2-Positive, HR-Positive, PIK3CA Mutant Early Breast Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Inavolisib
  • Sponsor:GBG Forschungs GmbH

Cardiac failure

Recruiting

Study on the Effects of Perindopril, Valsartan, and Glyceryl Trinitrate in Women with Asymptomatic Heart Failure

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Albumin
  • Sponsor:University Hospital Maastricht

Study on the Effects of Carboplatin and Cisplatin in Patients with Early-Stage, Intermediate-Risk Cervical Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:CEEGOG z.s.

Vulval cancer

Recruiting

Study Comparing Chemoradiation and Chemotherapy with Cisplatin, Paclitaxel, and Carboplatin for Patients with Advanced Vulvar Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Study on Treatment Options for Patients with Oligometastatic Pancreatic Cancer: Comparing Oxaliplatin, Fluorouracil, Folinic Acid, and Drug Combination

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Universitaetsmedizin Goettingen

Long-Term Follow-Up Study for Patients Treated with Idecabtagene Vicleucel or Lisocabtagene Maraleucel for Cancer

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:BMS-986515
  • Sponsor:Celgene Corp.

Study on Long-Term Safety of Secukinumab for Patients with Psoriatic Arthritis, Ankylosing Spondylitis, and Severe Chronic Plaque Psoriasis

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Secukinumab
  • Sponsor:Novartis Pharma AG

Study on Early Use of Candesartan vs Placebo for People with Genetic Risk of Dilated Cardiomyopathy

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Candesartan Cilexetil
  • Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Universitario Puerta De Hierro Majadahonda

Medulloblastoma

Recruiting

Study on the Effectiveness of Bevacizumab and Drug Combination for Children with Recurrent or Progressive Medulloblastoma, Ependymoma, and ATRT

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Bevacizumab
  • Sponsor:Medical University Of Vienna

Study on ONC201 and Everolimus with Radiotherapy for Newly Diagnosed Diffuse Intrinsic Pontine Glioma and Other Diffuse Midline Gliomas in Children, Adolescents, and Adults

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dordaviprone
  • Sponsor:Institut Gustave Roussy

Study of prucalopride in patients with gastro-esophageal reflux disease who have incomplete response to standard acid-reducing therapy

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Prucalopride
  • Sponsor:UZ Leuven

Endometrial cancer+38

Recruiting

Study of DS-3939a for Patients with Advanced or Metastatic Solid Tumors

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:DS-3939A
  • Sponsor:Daiichi Sankyo Inc.

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Hasselt

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on non-small cell lung cancer treatments and novel therapeutic approaches for various stages of breast cancer. Multiple trials are evaluating innovative combination therapies and targeted treatments.

  • Advanced NSCLC therapies
  • Triple-negative breast cancer treatments
  • Mesothelioma interventions

Research emphasizes personalized treatment approaches and immunotherapy combinations.

02 Cardiovascular Studies

Innovative research examining heart failure treatments and surgical interventions. Studies focus on preventing complications during open-heart surgery and managing various cardiac conditions.

  • Cardiac surgery outcomes
  • Atrial fibrillation management
  • Heart failure treatments

Trials aim to improve patient outcomes and develop safer surgical procedures.

03 Immunology and Infectious Diseases

Studies exploring SARS-CoV-2 immunity in vulnerable populations and investigating treatments for various infections. Research includes both preventive measures and therapeutic interventions.

  • COVID-19 immunity studies
  • Hepatitis B management
  • Candidiasis treatments

Focus on long-term immunity monitoring and novel therapeutic approaches.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.